
Tangramed Biotech is revolutionizing access to medicines through AI-powered Multimodal Therapies (MMTs) for aging and age-related diseases with high unmet medical needs. They combine multiple drugs to target complementary modes of action simultaneously, integrating proprietary AI and experimental tools. Their approach aims to address complex diseases like Alzheimer's and glioblastoma, while ensuring affordability for patients, by overcoming the challenges of new drug development and clinical trials. Founded by seasoned scientists and entrepreneurs with deep expertise in Bio-AI and drug screening, Tangramed is building a translational platform encompassing digital (Bio AI), experimental, and clinical phases.

Tangramed Biotech is revolutionizing access to medicines through AI-powered Multimodal Therapies (MMTs) for aging and age-related diseases with high unmet medical needs. They combine multiple drugs to target complementary modes of action simultaneously, integrating proprietary AI and experimental tools. Their approach aims to address complex diseases like Alzheimer's and glioblastoma, while ensuring affordability for patients, by overcoming the challenges of new drug development and clinical trials. Founded by seasoned scientists and entrepreneurs with deep expertise in Bio-AI and drug screening, Tangramed is building a translational platform encompassing digital (Bio AI), experimental, and clinical phases.